Cash And Equivalent Endring Dato
AstraZeneca USD 4.87B 793M 2023-09
Biogen USD 1.05B 1.24B 2023-12
Genmab DKK 14.27B 3.4B 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
GRIFOLS EUR 529.58M 45.35M 2023-12
Hikma Pharmaceutical USD 1000K 22M 2022-12
Incyte USD 3.21B 13.85M 2023-12
Merck EUR 2.37B 604M 2023-09
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Roche Holding CHF 3.72B 1.27B 2023-06
UCB EUR 457M 442M 2023-06
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Galapagos Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.